Clearmind Medicine Inc.

CMND·NasdaqCM·Healthcare
Compare
5.920.00 (0.00%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close5.92
Open5.99
Day range5.816.11
52-week range5.252,531.20
Off day high−3.06%
Off 52-week high−99.77%
Volume3.49K
Avg. volume (3M)57.49K
Market cap3.00M
EPS (TTM)-461.20
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.51
Shares outstanding507.40K
Short interest0.76% of float
Earnings date—
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
CMND SILO QNTM JUNS 18H0.F PHRM.CN
Market cap 3.00M 2.93M 14.21M 3.24M 5.11M 4.55M
P/E (TTM) — — — — — —
Forward P/E — -1.9 -0.3 41.0 — -0.5
Price/book 0.1 0.3 2.1 -4.5 -1.1 7.1
Dividend yield — — — — — —
1-year change −99.75% −82.01% −74.27% −97.59% −25.00% −52.38%
Today 0.00% +3.91% 0.00% +1.23% −23.81% −16.67%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All CMND news ›
markets.businessinsider.com·Positive

Psychedelic: Clearmind initiates Phase IIa of CMND-100 trial

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a Phase IIa study initiation, ... Psychedelic: Clearmind initiates Phase IIa of CMND-100 trial In this week’s “Psychedelic,”…

markets.financialcontent.com··2 outletsPositive

Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint

Clearmind Medicine has received Independent Data and Safety Monitoring Board (DSMB) approval to advance its clinical evaluation of CMND‑100 in patients with Alcohol Use Disorder (AUD) - a key milestone in the progression of the Company’s…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

38mentions in 30 days
15with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 38 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance